reported on the first-of-its kind UB study called Comprehensive Assessment of Severely Affected MS that will examine why 5-10% of multiple sclerosis patients develop severe disease. The story quoted principal investigator Robert Zivadinov, MD, PhD,
professor of neurology and professor of biomedical informatics in the Department of Neurology
, who said: “These people have been really neglected for too many years.” He added: “The usual tests in Multiple Sclerosis, clinical ones want you to move, to walk, measure your walking ability, measure your cognitive ability. And so with this study, we had to first invent how to even examine these people — in some standardized way,” The study will follow 60 patients at a Boston residential facility and 60 Western New York patients.